{"nct_id":"NCT04126200","title":"Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2019-10-07","start_date_type":"ACTUAL","primary_completion_date":"2029-02-12","primary_completion_date_type":"ESTIMATED","completion_date":"2029-02-12","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}